PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

This project is part of the EDCTP2 Programme supported by the European Union.
EDCTP
EU

Search

Search

  • About us
    • What we do
    • Governance
    • PAMAfrica scientists
  • Work packages
    • Next-generation drug combination for uncomplicated malaria
    • First malaria treatment for babies under 5kg
    • New medicine for treatement of severe malaria
    • Building research capacity
  • Consortium partners
  • Newsroom
    • Resources
    • News
Search
Photo: Dtimiraos/iStock

First student selected for an MSc program

Read more

Dr Halidou Tinto elected Fellow of the African Academy of Sciences

Read more

Photo: Dr Tinto – ©IT CRUN

Take a look at our infographic!

Read more

Photo: Damien Schumann

Read EDCTP's interview with Dr Tim Wells, Chief Scientific Officer of MMV

Read more

Photo: BrianAJackson/iStock

Take a look at our infosheet!

Read more

Photo: Alex Radelich

Portfolio approach to developing the next-generation of malaria treatments for Africa

1

Work packages

Next-generation drug combination for uncomplicated malaria

First malaria treatment for babies under 5kg

New medicine for treatment of severe malaria

Building research capacity in Africa

1

PAMAfrica scientists

Dr Yeka Adoke

Ph.D, Director and Principal Investigator at IDRC (WP 1)

Miss Sarita Barsainya

Masters in Pharmacy, Global Trial Director at Novartis (WP 3)

Dr Quique Bassat

PhD, Head of the Malaria Programme at ISGlobal (WP 2)

Dr Helen Demarest

PhD, Director, Clinical Operations for MMV (WP 4)

Dr Ghyslain Mombo-Ngoma

MD, PhD, Head of Clinical Operations at CERMEL (WP 1 - WP 3)
View more profiles of our scientists

Consortium Partners

MMV

Medicines for Malaria Venture (MMV) is a leading product development partnership (PDP) in antimalarial drug research in its 20th year.

Novartis

Novartis is reimagining medicine to improve and extend people’s lives. 

Tubingen logo

The Eberhard Karls Universität Tübingen

The Eberhard Karls Universität Tübingen is one of Europe’s oldest universities, with key strengths in Sciences and Life Sciences. Within the Faculty of Medicine, the Institute of Tropical Medicine (ITM) is an established Centre of Excellence (since 2007).

CERMEL

Manhiça Health Research Centre

Manhiça Health Research Centre is a research institution managed by Manhiça Foundation, whose mission is to promote and conduct biomedical research in health priority areas to promote and safeguard the health of the population.

Groupe de Recherche Action en Santé logo

GRAS

The Groupe de Recherche Action en Santé (GRAS) is a private institute based in Burkina Faso, operating since 2008 in the field of health research.

IDRC

IDRC conducts research in infectious diseases including Malaria, HIV, Tuberculosis and other diseases of public health importance through collaboration and partnership. 

CRUN

The CRUN’s mission is to provide evidence-based information for the health care of populations living in tropical countries. 

ISGlobal logo

ISGlobal

The ultimate goal of ISGlobal is to help close the gaps in health disparities between and within different regions of the world.

1

Resources

03 Sep 2020

PAMAfrica Infographic

Article
12 Jun 2020

PAMAfrica Infosheet

Article
June 2020

The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound

Travel Medicine and Infectious Disease
Peer-reviewed article
Photo:
January 2020

Antimalarial development: a step forward in the global fight against antimicrobial resistance

MMV
Article
View all

Contact us

infopamafrica [at] mmv [dot] org

A Remora website by Manta Ray Media